Why choose CatSci?

State-of-the-art equipment

Our HPAPI dedicated suite includes a power handling isolator that enables operation at OEL 0.1 – 1.0 µg/m3 (OEB-5).

Early Phase Development

For your pre-clinical and Phase I demands, our HPAPI capabilities offer route design, process invention and characterisation, crystallisation, isolation and drying, analytical method development and sample analysis, and up to 10g scale non-GMP material supply.

Late Phase Development

Our powder handling isolator includes a parallel reactor workstation technology, compatible with PAT and automated sampling. This can be used for designed experimentation that can be either data-driven or mechanism-guided.

Partnering from pre-clinical to product launch

  • High Potency API Development High Potency API Development

    Route design

    Process invention & characterisation

    Crystallisation, isolation & drying

    Analytical method development & sample analysis

    Up to 10g-scale non-GMP material supply

    Parallel reactor workstation technology

    Process data collection

    Up to 10g-scale non-GMP material supply

    Analytical method development & sample analysis